Tag Archives: Starr Cancer Consortium

Mechanism of mutant histone protein in childhood brain cancer revealed

Scientists in David Allis’s laboratory have shown how a mutated histone protein inhibits an enzyme, which normally keeps cell growth in check, and causes a rare form of pediatric brain cancer called DIPG. Their findings reveal a mechanism for inhibiting enzymes and could lead to the development of pharmaceuticals that mimic the action of these mutant proteins.

More »

Tags: , ,

David Allis awarded $1 million grant from Starr Cancer Consortium

Allis leads one of five cancer research teams that are winners of $5 million in grant awards from The Starr Foundation’s Sixth Starr Cancer Consortium Grant Competition.
More »

Tags: , ,